EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
   3.4.22.26 | 0.16 |
- |
substrate GDR-7-amido-4-methylcoumarin, pH and temperature not specified in the publication |
755327 |
| 3.4.22.26 | 0.65 |
- |
substrate PQPQYVA-7-amido-4-methylcoumarin, pH and temperature not specified in the publication |
755327 |
| 3.4.22.26 | 0.98 |
- |
substrate tert-benzyloxycarbonyl-PKSQSVA-7-amido-4-methylcoumarin, pH and temperature not specified in the publication |
755327 |
| 3.4.22.26 | 1.47 |
- |
substrate PKSQSVA-7-amido-4-methylcoumarin, pH and temperature not specified in the publication |
755327 |
| 3.4.22.26 | 1.63 |
- |
substrate tert-benzyloxycarbonyl-PQPQYVA-7-amido-4-methylcoumarin, pH and temperature not specified in the publication |
755327 |
| 3.4.22.26 | 1.95 |
- |
substrate tert-benzyloxycarbonyl-RGD-7-amido-4-methylcoumarin, pH and temperature not specified in the publication |
755327 |
| 3.4.22.26 | 2.26 |
- |
extract from independent PA3 prostate tumor undergoes 1 round of purification on the anion exchanger, 33fold purification, activity of samples is determined by using a 3-stage chromogenic assay |
697471 |
| 3.4.22.26 | 2.32 |
- |
extract from independent PA3 prostate tumor undergoes 1 round of purification on the anion exchanger, 30fold purification, activity of samples is determined by using a 3-stage chromogenic assay |
697471 |
| 3.4.22.26 | 2.93 |
- |
substrate AVSQSKP-7-amido-4-methylcoumarin, pH and temperature not specified in the publication |
755327 |
| 3.4.22.26 | 3.09 |
- |
substrate PQVR-7-amido-4-methylcoumarin, pH and temperature not specified in the publication |
755327 |
